Loading
NANOVERY
Founded by scientists specialised in Nanotechnology, Medicinal Chemistry and Artificial Intelligence, we are on a mission to enable early detection of cancer through a rapid and affordable blood testBacked by academics at top universities, clinicians, industrial leaders, and Entrepreneur First.
Funding
Every round, secondary, debt facility or acquisition involving NANOVERY that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—